Success Stories: Research Scientist Secured EB2-NIW Approval in Biomedical Sciences in Just 8 Days through the Premium Processing

Posted by wegreened on September 3, 2025 in NIW, Biomedical Sciences

Client’s Testimonial:

“The Chen Immigration team provided strong support throughout my EB-2 NIW petition preparation. The reference and petition letters were well-structured, and my questions were addressed professionally. Overall, I'm satisfied with the service and appreciate the clarity and guidance during the process. Looking forward to working with the team again on my EB-1A petition.”

On July 5^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist in the Field of Biomedical Sciences (Approval Notice).

General Field: Biomedical Sciences

Position at the Time of Case Filing: Research Scientist

Approval Notice Date: July 5^th, 2025

Processing Time: 8 days (Premium Processing Requested)

Case Summary:

North America Immigration Law Group (NAILG) is pleased to announce the swift approval of an I-140 EB2-NIW (National Interest Waiver) petition for our client, a research scientist specializing in biomedical sciences. After closely evaluating his extensive expertise and research accomplishments, we confidently recognized the substantial merit and national importance of his work, making him an excellent candidate for the EB2-NIW category. Our team meticulously prepared the petition and filed it with the direct premium processing, resulting in a rapid approval in just 8 days.

Review of Client's Strong Qualifications and National Impact

Our client’s research involves developing advanced mass spectrometry-based proteomics workflows to facilitate precision oncology and biomarker discovery. His work directly addresses one of the most critical healthcare challenges in the United States—cancer, which continues to significantly impact public health, with millions of new cases annually and hundreds of thousands of fatalities. His proposed research promises to substantially enhance the accuracy of cancer diagnosis and improve targeted therapies, aligning directly with the Cancer Moonshot initiative's national priority of transforming cancer care through precision oncology.

NAILG’s review of his achievements and proposed research confirmed his position at the forefront of biomedical sciences, highlighting his potential to continue contributing significantly to cancer research and treatment innovation.

Key Accomplishments Reflecting Client's Global Recognition

NAILG comprehensively documented his extensive accomplishments, underscoring his exceptional qualifications, including:

● A strong publication record comprising 18 peer-reviewed journal articles, published in top-tier journals including Nature, Cancer Cell, and Cell.

● An outstanding citation record of over 1,200 citations indicates the widespread global recognition and the substantial impact of his research.

● Performed at least 29 peer reviews for leading scientific journals, confirming his respected expertise in the field.

● Authored at least 13 highly-cited papers ranking among the top 1%, the top 10%, and the top 20% most cited articles for their publication years, further affirming his influential contributions to biomedical sciences.

● Served as a guest editor for a renowned journal, highlighting his recognition as a trusted authority in the field of biomedical sciences.

Endorsements from Renowned Experts in the Field

The petition included compelling testimonial letters from renowned experts, confirming the significance and innovative nature of our client's contributions. One of these letters from a leading scientist explicitly emphasized his groundbreaking research, further solidifying his standing in the global scientific community. An excerpt from the letters noted:

“In conclusion, [client’s] research into tackling the molecular heterogeneity of cancer using mass spectrometry-based proteomics provides the nation with new techniques to overcome challenges in cancer diagnostics and develop more effective treatments. Moreover, his role in these projects is solidifying his unique expertise in mass spectrometry-based proteomics and biomarker discovery, positioning him perfectly to continue making essential advances in cancer diagnostics and personalized treatment strategies and in biochemistry overall. Because of the considerable benefits that [client’s] work offers the U.S., it is my professional opinion that he ought to be given every opportunity to continue his valuable work here.”

Premium Processing Leads to a Swift Approval

Thanks to NAILG’s careful preparation, meticulous documentation, and strategic submission under premium processing, USCIS swiftly approved our client's I-140 EB2-NIW petition in just 8 days. This remarkably quick approval underscores the strength of his qualifications and the clear national importance of his work in biomedical sciences.

We congratulate our client on this significant achievement and look forward to his continued contributions to precision oncology, cancer biomarker discovery, and improved patient care in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%